Navigation Links
FDA Approves U.S. Market Return for octagam® Following Octapharma's Implementation of Enhanced Safety Measures
Date:11/4/2011

syndrome and severe combined immunodeficiencies.

About the Octapharma Group

Headquartered in Lachen, Switzerland, Octapharma AG is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation for over 28 years. Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell-lines, including immune globulin intravenous (IGIV). In the U.S., Octapharma's IGIV product, octagam® (immune globulin intravenous [human] 5%), is used to treat primary immune deficiencies, and Octapharma's Albumin (human)® is indicated for the restoration and maintenance of circulating blood volume. Octapharma's wilate® (Von Willebrand Factor/Coagulation Factor VIII Complex [human]) received orphan drug exclusivity from the U.S. Food and Drug Administration (FDA) for the treatment of certain types of Von Willebrand Disease (VWD). Octapharma employs over 4,000 people and has biopharmaceutical experience in 80 countries worldwide, including the United States, where Octapharma USA is located in Hoboken, N.J.  Octapharma operates two state-of-the-art production sites licensed by the FDA, providing a high level of production flexibility. For more information, please visit www.octapharma.com or www.wilateusa.com.

Forward-looking statements

This news release contains forward-looking statements, which include known and unknown risks, uncertainties and other factors not under
'/>"/>

SOURCE Octapharma USA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
2. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
3. FDA Approves Onfi To Treat Severe Type of Seizures
4. FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA®
5. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
6. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
7. FDA Approves Combination Therapy Juvisync
8. FDA Approves Cialis to Treat Benign Prostatic Hyperplasia
9. FDA Approves Remicade to Treat Ulcerative Colitis in Children Older Than 6 Years
10. FDA Approves Soliris for Rare Pediatric Blood Disorder
11. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014 GenomeDx Biosciences today announced ... American Society for Radiation Oncology (ASTRO) Annual Meeting ... Classifier, a genomic test capable of predicting aggressiveness ... improve patient outcomes for prostate cancer patients following ... recently published study that demonstrates how Decipher test ...
(Date:9/15/2014)... 2014 /PRNewswire/ -  Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... with a focus on Omega-3 therapies for cardiovascular ... Board of Directors approved the granting of stock ... close of business on Friday, September 12, 2014. ... shares of the Company were granted in accordance ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- "Spain Aesthetic Lasers and Energy Devices ... on the Spain Aesthetic Lasers and Energy Devices ... US dollars, volume (in units) and average prices ... Contouring Devices (Laser-Assisted Liposuction (LAL) Devices (Nd:YAG and ... Liposuction (UAL) Devices and Power Assisted Liposuction (PAL) ...
Breaking Medicine Technology:Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 2Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes 3Pivotal Therapeutics Grants Incentive Stock Options 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 2Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 3Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 4Spain Aesthetic Lasers and Energy Devices Market (LAL, RFAL, PAL, HIFU) Outlook to 2020 5
... Md., Feb. 23, 2012  Northwest Biotherapeutics (OTC.BB: NWBO) (NW ... trial sites open and recruiting across the United States ... immune therapy for Glioblastoma multiforme (GBM), the most lethal ... ahead of schedule, as the Company had projected to ...
... SOUTH SAN FRANCISCO, Calif., Feb. 23, 2012  Rigel Pharmaceuticals, ... James M. Gower, chairman and chief executive officer, and ... of Rigel, will participate at two upcoming investor conferences. ... (Logo:  http://photos.prnewswire.com/prnh/20030226/RIGLLOGO ) Citi 2012 Global ...
Cached Medicine Technology:NW Bio Reaches 30 Clinical Trial Sites Ahead of End-of-Q1 Projection 2NW Bio Reaches 30 Clinical Trial Sites Ahead of End-of-Q1 Projection 3Rigel Announces Participation at Two Investor Conferences 2
(Date:9/16/2014)... Florida (PRWEB) September 16, 2014 ... of monthly specials this month, kicking off September ... day spa in Clearwater, FL chose to highlight ... for immediate activation upon contact with the skin. ... part of their best-selling lumafirm® anti-aging line. The ...
(Date:9/16/2014)... The Fertility Centers of New England is proud ... collaboration will give patients access to high-quality frozen donor ... Fertility Centers of New England. , Fairfax Egg Bank ... selection of frozen donor eggs. Access to frozen donor ... The Donor is already screened and her eggs ...
(Date:9/15/2014)... With the variety of drugs passing ... know the details on each one. However, it is ... falling into their teen’s hands. , Synthetic marijuana ... high school students. With varied, misleading and potentially unreliable ... can be difficult for parents to separate the truth ...
(Date:9/15/2014)... iFitDress.com, one of the most distinguished dress companies, ... evening dresses to its online store. In addition, the ... products. They are now provided at very low prices, up ... has confidence in the newly unveiled sapphire evening outfits. “I ... from all over the world. Up to now, over 200 ...
(Date:9/15/2014)... 2014 Aging skin inevitably wrinkles, thins and ... is loss of collagen production. By age 60, skin ... to this slow down. Collagen holds up skin structure. , ... be boosted. There are several ways to do this, but ... cells (non-embryonic). , "The cost is higher than other types ...
Breaking Medicine News(10 mins):Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3Health News:Beautiful Sapphire Evening Dresses Provided By iFitDress.com 2Health News:A Superior Way to Make Skin Younger and Assure Continual Collagen Production, from Sublime Beauty® 2
... A Pole who spent 19 years in a coma has woken up ... are no longer in power, a television station announced Friday. ... by a train in 1988, the private channel Polsat said. In an ... ,"She's the one who always took care of me. She ...
... man has contracted the deadly bird flu virus, becoming the country's ... Saturday. ,The 19-year-old man tested positive for the H5N1 strain ... Institute of Tropical Medicine in Hanoi, a doctor there told AFP. ... the victim had been admitted on May 19 and was now ...
... one source of counterfeit medicines, seized in the European Union ... ,About 31 percent of all fake medicines seized ... percent) and China (8). The three countries are responsible for ... report. ,The seized fake medicines included Viagra, Cialis ...
... found evidence that tropical cyclones and hurricanes play an ... transport heat and maintain the climate of North America ... University professor of earth and atmospheric sciences who led ... by MIT professor Kerry Emanuel that suggests there is ...
... Inc. announced it has successfully expanded the potential ... ELISA diagnostic research test, FAS-Detect(TM) ELISA for ... ,The current diagnostic technique for this disease is ... use presently, FASgen anticipates the opportunity for use ...
... a third child, but the actor is recoiling from making ... not come out in the open to declare that his ... who interviewed the actor, is of the view that if ... forward, awareness about autism would get a major boost. ...
Cached Medicine News:Health News:India Main Source of Counterfeit Medicines Seized in Europe 2Health News:India Main Source of Counterfeit Medicines Seized in Europe 3Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:FASgen Announces New Diagnostic Research Test for Steatohepatitis 2Health News:Travolta Maybe Reluctant to Publicaly Discuss About Sons Autism 2
... ,Smaller slot surface area results in ... ,Small slot dimensions require less sample than ... intense signal generated with the slot-blotter allows you ... Accepts all types of transfer membranes ...
... system consists of four basic components: sample well ... clamping plate (see diagram). The sample well plate ... dots, or slots (see below). All three plates ... accessory plate in conjunction with a complete system. ...
... (slot format) microfiltration units provide a reproducible ... in solution onto nitrocellulose or Zeta-Probe membrane. ... using interchangeable templates to form the 96-well ... SF apparatus. Each is available as a ...
... plastic tray. Ideal for staining westerns and ... for multipurposes. Pour spouts in each corner ... label may be used for identification. Lid ... or shakers for staining several gels simultaneously. ...
Medicine Products: